These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15156311)

  • 21. Tramadol hydrochloride extended-release once-daily in the treatment of osteoarthritis of the knee and/or hip: a double-blind, randomized, dose-ranging trial.
    DeLemos BP; Xiang J; Benson C; Gana TJ; Pascual ML; Rosanna R; Fleming B
    Am J Ther; 2011 May; 18(3):216-26. PubMed ID: 20215961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A; Ma C; Ahdieh H; Galer BS
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A fixed-dose combination of naproxen and esomeprazole magnesium has comparable upper gastrointestinal tolerability to celecoxib in patients with osteoarthritis of the knee: results from two randomized, parallel-group, placebo-controlled trials.
    Cryer BL; Sostek MB; Fort JG; Svensson O; Hwang C; Hochberg MC
    Ann Med; 2011 Dec; 43(8):594-605. PubMed ID: 22017620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of nimesulide on pain and on synovial fluid concentrations of substance P, interleukin-6 and interleukin-8 in patients with knee osteoarthritis: comparison with celecoxib.
    Bianchi M; Broggini M; Balzarini P; Franchi S; Sacerdote P
    Int J Clin Pract; 2007 Aug; 61(8):1270-7. PubMed ID: 17590218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-blind, randomized, controlled parallel group study evaluating the efficacy and safety of acemetacin for the management of osteoarthritis.
    Chou CT; Tsai YY
    Int J Clin Pharmacol Res; 2002; 22(1):1-6. PubMed ID: 12395912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized, multicentre, double-blind, parallel-group study to assess the adverse event-related discontinuation rate with celecoxib and diclofenac in elderly patients with osteoarthritis.
    Dahlberg LE; Holme I; Høye K; Ringertz B
    Scand J Rheumatol; 2009; 38(2):133-43. PubMed ID: 19165648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. S-adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: a double-blind cross-over trial. [ISRCTN36233495].
    Najm WI; Reinsch S; Hoehler F; Tobis JS; Harvey PW
    BMC Musculoskelet Disord; 2004 Feb; 5():6. PubMed ID: 15102339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Celecoxib compared with sustained-release paracetamol for osteoarthritis: a series of n-of-1 trials.
    Yelland MJ; Nikles CJ; McNairn N; Del Mar CB; Schluter PJ; Brown RM
    Rheumatology (Oxford); 2007 Jan; 46(1):135-40. PubMed ID: 16777855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, double-blind, multicenter trial of nimesulide-beta-cyclodextrin versus naproxen in patients with osteoarthritis.
    Fioravanti A; Storri L; Di Martino S; Bisogno S; Oldani V; Scotti A; Marcolongo R
    Clin Ther; 2002 Apr; 24(4):504-19. PubMed ID: 12017396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.
    Balanescu AR; Feist E; Wolfram G; Davignon I; Smith MD; Brown MT; West CR
    Ann Rheum Dis; 2014 Sep; 73(9):1665-72. PubMed ID: 23852695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and tolerability of celecoxib compared with diclofenac slow release in the treatment of acute ankle sprain in an Asian population.
    Nadarajah A; Abrahan L; Lau FL; Hwang LJ; Fakir-Bolte C
    Singapore Med J; 2006 Jun; 47(6):534-42. PubMed ID: 16752024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial.
    Bensen WG; Fiechtner JJ; McMillen JI; Zhao WW; Yu SS; Woods EM; Hubbard RC; Isakson PC; Verburg KM; Geis GS
    Mayo Clin Proc; 1999 Nov; 74(11):1095-105. PubMed ID: 10560596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip.
    Luyten FP; Geusens P; Malaise M; De Clerck L; Westhovens R; Raeman F; Vander Mijnsbrugge D; Mathy L; Hauzeur JP; De Keyser F; Van den Bosch F
    Ann Rheum Dis; 2007 Jan; 66(1):99-106. PubMed ID: 16815864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.
    Clegg DO; Reda DJ; Harris CL; Klein MA; O'Dell JR; Hooper MM; Bradley JD; Bingham CO; Weisman MH; Jackson CG; Lane NE; Cush JJ; Moreland LW; Schumacher HR; Oddis CV; Wolfe F; Molitor JA; Yocum DE; Schnitzer TJ; Furst DE; Sawitzke AD; Shi H; Brandt KD; Moskowitz RW; Williams HJ
    N Engl J Med; 2006 Feb; 354(8):795-808. PubMed ID: 16495392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Celecoxib versus diclofenac in the management of osteoarthritis of the knee.
    McKenna F; Borenstein D; Wendt H; Wallemark C; Lefkowith JB; Geis GS
    Scand J Rheumatol; 2001; 30(1):11-8. PubMed ID: 11252686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fixed-dose combination of enteric-coated naproxen and immediate-release esomeprazole has comparable efficacy to celecoxib for knee osteoarthritis: two randomized trials.
    Hochberg MC; Fort JG; Svensson O; Hwang C; Sostek M
    Curr Med Res Opin; 2011 Jun; 27(6):1243-53. PubMed ID: 21524238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of tramadol/acetaminophen tablets (Ultracet) as add-on therapy for osteoarthritis pain in subjects receiving a COX-2 nonsteroidal antiinflammatory drug: a multicenter, randomized, double-blind, placebo-controlled trial.
    Emkey R; Rosenthal N; Wu SC; Jordan D; Kamin M;
    J Rheumatol; 2004 Jan; 31(1):150-6. PubMed ID: 14705234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aceclofenac vs paracetamol in the management of symptomatic osteoarthritis of the knee: a double-blind 6-week randomized controlled trial.
    Batlle-Gualda E; Román Ivorra J; Martín-Mola E; Carbonell Abelló J; Linares Ferrando LF; Tornero Molina J; Raber Béjar A; Fortea Busquets J
    Osteoarthritis Cartilage; 2007 Aug; 15(8):900-8. PubMed ID: 17387026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 12-month, multicenter, prospective, open-label trial of radiographic analysis of disease progression in osteoarthritis of the knee or hip in patients receiving celecoxib.
    Tindall EA; Sharp JT; Burr A; Katz TK; Wallemark CB; Verburg K; Lefkowith JB
    Clin Ther; 2002 Dec; 24(12):2051-63. PubMed ID: 12581544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of additional 200-mg dose of celecoxib in adult patients with postoperative pain following extraction of impacted third mandibular molar: a multicenter, randomized, double-blind, placebo-controlled, phase II study in Japan.
    Saito K; Kaneko A; Machii K; Ohta H; Ohkura M; Suzuki M
    Clin Ther; 2012 Feb; 34(2):314-28. PubMed ID: 22284900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.